| Shagoon Anand, | |
|
638 Brandywine Pkwy, West Chester, PA 19380-4278 | |
| (610) 436-3600 | |
| Not Available |
| Full Name | Shagoon Anand |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 638 Brandywine Pkwy, West Chester, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003132051 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OC011371 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Shagoon Anand, 638 Brandywine Pkwy, West Chester, PA 19380-4278 Ph: () - | Shagoon Anand, 638 Brandywine Pkwy, West Chester, PA 19380-4278 Ph: (610) 436-3600 |
News Archive
Agilent Technologies Inc. today announced a solution for exon analysis based on SurePrint G3 Exon Microarrays. The solution provides a major expansion of Agilent's portfolio of gene expression reagents, microarrays and bioinformatics systems. This new system, available in mid-November, enables researchers to examine alternately expressed exons according to recently updated content, providing a global picture of RNA expression.
Eliza Corporation ("Eliza"), the pioneer and recognized leader in Health Engagement Management, has been awarded a grant by the Workforce Training Fund through the Commonwealth of Massachusetts, Executive Office of Labor and Workforce Development.
Two contracts for advanced development of drugs to treat skin and lung injuries associated with acute radiation syndrome (ARS) were awarded this week by the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA). These contracts are the first by BARDA to address the skin and lung injuries that arise from acute exposure to high levels of ionizing radiation - the type of radiation that results from a nuclear blast.
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, presented positive results from two pivotal Phase 3 clinical trials of the investigational product, PA32540, at The American Heart Association (AHA) Scientific Sessions 2012, as Poster #12057: Treatment Continuation and Cardiovascular Safety of Antiplatelet Therapy with PA32540, A Tablet with Enteric-Coated Aspirin and Immediate-Release Omeprazole: Results of Two 6-Month, Phase 3 Studies.
The report from the congressional advisory group MedPAC assesses a variety of issues, including penalties that Medicare has recently begun imposing on hospitals and how that affects facilities largely serving poor patients.
› Verified 7 days ago
Kelly Rodden, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 638 Brandywine Pkwy, West Chester, PA 19380 Phone: 610-436-3600 | |
Melissa Anne Szakal, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1380 Enterprise Dr Ste 200, West Chester, PA 19380 Phone: 610-436-3600 | |
Linnette Siedler, MSOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 638 Brandywine Pkwy, West Chester, PA 19380 Phone: 215-293-8882 | |
Molly Kathleen Templin, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1380 Enterprise Dr Ste 200, West Chester, PA 19380 Phone: 610-436-3600 | |
Mollie Marko, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 638 Brandywine Parkway, West Chester, PA 19380 Phone: 610-436-3600 | |
Olivia Johnson, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 638 Brandywine Pkwy, West Chester, PA 19380 Phone: 610-436-3600 |